INDUSTRY EXPERT ARTICLES

Innovative biotechnology companies have the potential to transform healthcare, developing new therapies that may improve, as well as extend, the lives of patients. Delivering on this promise is an epic journey that may take one to two decades, unimaginable amounts of cash, and surviving the notorious valley of death. Read what Christopher J. Calhoun, Chairman & CEO of PARACRINE has to say.

Medical Device News Magazine spoke with CEO Mark Goldwasser about the potential of the medtech sector, companies that Ceros has funded so far, and what he sees ahead. 

Precision prescribing used to be a trending vision; now it’s a necessary reality. Gustavo Bernard Esquivel, MD, Ph.D., MHA Chief Medical Officer, GenXys Health Care Systems, provides his views in this article.

In 1974, we were introduced to Colonel Steve Austin, an astronaut who became the world’s first “bionic” man after a test flight crash. He was

Magnetoencephalography is often overlooked by physicians during the referral stage. Read Professor Stefano Seri MD, FRCP views.